Nifedipine serum levels in pregnant women undergoing tocolysis with nifedipine

Journal of Obstetrics and Gynaecology

Volumn 27, Issue 3, 2007, Pages 260-263

  Marin, T Zodan ^a   Meier, R ^a   Kraehenmann, F ^a   Burkhardt, T ^a   Zimmermann, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Nifedipine; Serum levels; Side effects; Tocolysis

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG INDUCED HEADACHE; FEMALE; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; NAUSEA; OBSERVATIONAL METHOD; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CROSS-SECTIONAL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; TOCOLYTIC AGENTS;

EID: 34247575222     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610701195009     Document Type: Article

References (13)

1. Bayer HealthCare LLC. 2002. Produktmonographie Perfalgan: Bayer.
2. Brown MA, McCowan LM, North RA, Walters BN. 1997. Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy. Medical Journal of Australia 166:640-643.
3. Ferguson JE 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. 1989. Nifedipine pharmacokinetics during preterm labor tocolysis. American Journal of Obstetrics and Gynecology 161:1485-1490.
4. Furberg CD, Psaty BM. 1996. Corrections to the nifedipine meta-analysis. Circulation 93:1475-1476.
5. Furberg CD, Psaty BM,Meyer JV. 1995. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 92:1326-1331.
6. Grundy JS, Foster RT. 1996. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clinical pharmacokinetics 30:28-51.
7. King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. 2003. Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine. Australian and New Zealand. Journal of Obstetrics and Gynaecology 43:192-198.
8. Oei SG, Mol BW, de Kleine MJ, Brolmann HA. 1999. Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstetricia et Gynecologica Scandinavica 78:783-788.
9. Pirhonen JP, Erkkola RU, Ekblad UU, Nyman L. 1990. Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodynamic responses, and uterine and fetal flow velocity waveforms. Obstetrics and Gynecology 76:807-811.
10. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS et al. 1995. The risk of myocardial infarction associated with antihypertensive drug therapies. Journal of the American Medical Association 274:620-625.
11. Schulz M, Schmoldt A. 1997. Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895-911.
12. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. 2001. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstetrics and Gynecology 97:840-847.
13. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. 2005. Severe hypotension and fetal death due to tocolysis with nifedipine. British Journal of Obstetrics and Gynaecology 112:509-510.